NDC 69704-101 - Co2 Polymer Mask Pack
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69704-101
- Package NDCs from labels
- 69704-101-01, 69704-101-02
- Manufacturer
- BUKWANG Co.,Ltd
- Effective date
- 2015-03-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Co2 Polymer Mask Pack - BUKWANG Co.,Ltd | BUKWANG Co.,Ltd | 2015-03-27 | HUMAN OTC DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Sodium Bicarbonate 5 gr | SODIUM BICARBONATE | TWIN MED LLC | 12cad432-99db-4a9b-8619-82794e29409e | 2026-03-01 | Warnings | 8MDF5V39QO |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX 6OZP39ZG8H |
| migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy | e130831a-ec50-467a-9e5c-ba6ebc7bef3c | 2026-02-26 | Warnings | 3G6A5W338E |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| Leader Extra Strength Effervescent Antacid and Pain Reliever | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Cardinal Health | c5d7bf5f-3e59-52f2-e053-2a95a90a4a00 | 2026-02-25 | Warnings | 8MDF5V39QO |
| Caffeine | CAFFEINE | CVS Pharmacy, Inc. | 6d9b3926-7198-5e00-e053-2a91aa0a9580 | 2026-02-24 | Warnings | 3G6A5W338E |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Acetaminophen , Caffeine and pyrilamine maleate | ACETAMINOPHEN , CAFFEINE AND PYRILAMINE MALEATE | Softgel Healthcare Pvt Ltd | 4a61313e-1b48-29df-e063-6394a90a27f0 | 2026-02-09 | Warnings | 3G6A5W338E |
| Ascomp with Codeine | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | Breckenridge Pharmaceutical, Inc. | 243a6aea-0f48-42a9-a85e-ff247ab94336 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Amneal Pharmaceuticals Private Limited | ba92f45a-0187-4709-aa70-462b8dae09e9 | 2026-02-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Geiss, Destin & Dunn Inc. | bf85fb32-66d4-4683-be9d-58ca4e9f272d | 2026-02-06 | Warnings | 3G6A5W338E |
| Dolex Fem | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Pharmadel LLC | b1cab10b-19f1-f5d5-e053-2995a90a4d5f | 2026-02-05 | Warnings | 3G6A5W338E |
| Alka-Seltzer Extra Strength Pain Relief | ANHYDROUS CITRIC ACID, ASPIRIN | Bayer HealthCare LLC. | 4a16b6e5-f0c6-e3a4-e063-6294a90a85ad | 2026-02-05 | Warnings | 3G6A5W338E |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Discount Drug Mart | ba64c29d-4a50-47b7-be6b-6cf7db11a97a | 2026-02-03 | Warnings | 3G6A5W338E |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | DOLGENCORP, LLC | 89eb8196-54c6-4e30-8655-502cc4313c8a | 2026-02-02 | Warnings | 3G6A5W338E |
| GOODYS MAX | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | 02b3a604-3f09-47e7-add1-b9038b3a268b | 2026-02-02 | Warnings | 3G6A5W338E |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.